Europe Anticholinergic Drugs market

germany accounted for the largest market share in 2017 in the europe anticholinergic drugs market, and is expected to reach usd 540.58 million in 2024 from usd 386.28 million in 2017. however, united kingdom is the fastest growing market, which is expected to grow at a cagr of 5.15% during the forecast period 2018 - 2024. hospital segment accounted for the largest market share in 2017, this market is expected to reach usd 1500.93 million in 2024 from usd 1068.88 million in 2017. this market is projected to grow at a cagr of 4.97% during the forecast period from 2018 - 2024. synthetic compounds segment accounted for the largest market share in 2017, this market is expected to reach usd 1657.32 million in 2024 from usd 1183.22 million in 2017. this market is projected to grow at a cagr of 4.93% during the forecast period from 2018 - 2024. however, synthetic compounds segment is the fastest growing market, which is expected to grow at a cagr of 4.93% during the forecast period 2018 - 2024. overactive bladder segment accounted for the largest market share in 2017, this market is expected to reach usd 942.71 million in 2024 from usd 710.67 million in 2017. this market is projected to grow at a cagr of 4.12% during the forecast period from 2018 - 2024. however, parkinson's disease segment is the fastest growing market, which is expected to grow at a cagr of 4.96% during the forecast period 2018 - 2024. oral segment accounted for the largest market share in 2017, this market is expected to reach usd 1574.18 million in 2024 from usd 1161.47 million in 2017. this market is projected to grow at a cagr of 4.44% during the forecast period from 2018 - 2024. however, parenteral segment is the fastest growing market, which is expected to grow at a cagr of 4.88% during the forecast period 2018 - 2024.